Table 4.
Diagnostic performance in predicting prostate cancer based on different ages
| Sensitivity | Specificity | Concordance | |
|---|---|---|---|
| Age < 60 y | |||
| tPSA | 95.20% | 16.40% | 36.59% |
| f/tPSA | 52.40% | 27.90% | 34.15% |
| PSAD | 95.20% | 31.10% | 47.56% |
| (f/t)/PSAD | 81.10% | 70.50% | 73.17% |
| fPSAD | 71.40% | 90.20% | 85.37% |
| 60 y ≤ age ≤ 80 y | |||
| tPSA | 96.30% | 7.30% | 48.66% |
| f/tPSA | 60.20% | 46.80% | 53.04% |
| PSAD | 95.30% | 32.30% | 61.56% |
| (f/t)/PSAD | 78.50% | 81.40% | 80.05% |
| fPSAD | 79.60% | 93.60% | 87.10% |
| Age > 80 y | |||
| tPSA | 100.00% | 4.80% | 62.96% |
| f/tPSA | 51.50% | 66.70% | 57.41% |
| PSAD | 100.00% | 23.80% | 70.37% |
| (f/t)/PSAD | 93.90% | 81.00% | 88.89% |
| fPSAD | 97.00% | 81.00% | 90.74% |